Recommended Starting Dose of Epinephrine for Anaphylaxis
For adults and children ≥30 kg: administer 0.3-0.5 mg (0.3-0.5 mL of 1:1000 solution) intramuscularly into the anterolateral thigh; for children <30 kg: administer 0.01 mg/kg (maximum 0.3 mg) intramuscularly into the anterolateral thigh. 1
Adult Dosing
The FDA-approved dosing for epinephrine in anaphylaxis is 0.3 to 0.5 mg intramuscularly for adults and children weighing ≥30 kg (66 lbs) 1. This represents the 1:1000 concentration (1 mg/mL), administered every 5-10 minutes as necessary.
The intramuscular route into the anterolateral thigh is strongly preferred over subcutaneous administration 2. While both routes are mentioned in guidelines, the IM route in the thigh produces higher and more rapid peak plasma epinephrine levels compared to subcutaneous or IM deltoid injections 3.
Important Dosing Consideration for Adults >50 kg
Recent evidence suggests that 0.5 mg may be superior to 0.3 mg in adults, particularly those weighing >50 kg. A 2026 retrospective study found that patients receiving an initial 0.5 mg dose had significantly lower rates of escalating care (7.1% vs 29.5%, p<0.001) compared to those receiving 0.3 mg 4. This included fewer requirements for additional IM doses and epinephrine infusions. The recommended weight-based dose of 0.01 mg/kg means that a 0.3 mg dose increasingly underdoses patients as weight increases above 30 kg 5.
Pediatric Dosing
For children <30 kg: 0.01 mg/kg of 1:1000 solution (maximum 0.3 mg) intramuscularly into the anterolateral thigh 2, 1.
Specific Weight-Based Recommendations:
- Children ≥25 kg: 0.3 mg (0.3 mL of 1:1000) 6
- Children 15-25 kg: 0.15 mg 7
- Children 7.5-15 kg: 0.15 mg autoinjector (though this exceeds 0.01 mg/kg, it is recommended given lack of alternatives) 7
- Infants <7.5 kg: 0.1 mg autoinjector if available 8
Critical Pediatric Caveat
For infants and small children weighing <15 kg, the 0.15 mg autoinjector dose exceeds the recommended 0.01 mg/kg dosing as weight decreases. However, the Canadian Society of Allergy and Clinical Immunology explicitly states that adverse effects from this relative overdose are expected to be mild and transient, and must be weighed against the potentially fatal consequences of not receiving epinephrine at all 7.
Route and Site of Administration
Intramuscular injection into the anterolateral thigh (vastus lateralis) is the preferred route and site 2, 3. This is superior to:
- Subcutaneous administration (slower absorption)
- IM deltoid injection (lower peak levels)
The 2005 JACI guidelines note that while IM thigh injection produces higher and more rapid peak plasma levels, "the clinical significance of these data is not known" 3. However, the pharmacokinetic advantage combined with ease of access makes this the standard recommendation across all major guidelines 3, 2, 8, 9.
Repeat Dosing
Repeat the same dose every 5-10 minutes as necessary if symptoms persist or recur 3, 1. Some guidelines suggest the 5-minute interval can be shortened if clinically indicated 3.
Approximately 7-18% of patients require more than one dose of epinephrine 9. The 2024 AHA/Red Cross guidelines recommend that if a person does not respond to initial epinephrine and EMS arrival will exceed 5-10 minutes, a repeat dose should be considered 9.
Common Pitfalls to Avoid
Do not inject into buttocks, digits, hands, or feet - risk of tissue injury and poor absorption 1
Do not delay epinephrine for antihistamines or corticosteroids - these are second-line agents only and should never be used alone 3
Do not use subcutaneous route when IM is available - slower and lower peak levels 2
Do not underdose adults >50 kg - consider 0.5 mg rather than 0.3 mg 4, 5
Avoid IV epinephrine in initial management - reserve for cardiac arrest or profoundly hypotensive patients who have failed multiple IM doses and IV volume resuscitation, due to risk of lethal arrhythmias 3
When to Escalate Beyond Initial IM Dosing
If anaphylaxis persists after 2-3 IM doses despite adequate fluid resuscitation, consider IV epinephrine infusion: prepare 1 mg (1 mL of 1:1000) in 250 mL D5W (concentration 4 mcg/mL), infuse at 1-4 mcg/min initially, titrating up to maximum 10 mcg/min 3. For children: 0.01 mg/kg (0.1 mL/kg of 1:10,000 solution; maximum 0.3 mg) 3.
There is no absolute contraindication to epinephrine in anaphylaxis 3, 8, 1, though elderly patients and those with cardiovascular disease require careful monitoring for arrhythmias and hypertension 8, 1.